Results 11 to 20 of about 58,795 (276)

Treatment of bulky lymph nodes in locally advanced cervical cancer: boosting versus debulking [PDF]

open access: yesInternational Journal of Gynecological Cancer, 2022
Objective Treatment strategies for bulky lymph nodes in patients with locally advanced cervical cancer scheduled for definitive chemoradiation include nodal boosting with radiotherapy, surgical debulking, or both.
E. Olthof   +14 more
semanticscholar   +6 more sources

Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage III C and IV epithelial ovarian cancer [PDF]

open access: gold, 2016
ObjectivesTo examine the cost-effectiveness of primary debulking surgery (PDS) when compared to neoadjuvant chemotherapy (NACT) in the management of epithelial ovarian cancer (EOC) using Surveillance, Epidemiology, and End Results data linked to Medicare
Gareth K. Forde   +2 more
openalex   +4 more sources

Comparison of debulking followed by stenting versus stenting alone for saphenous vein graft aortoostial lesions: immediate and one-year clinical outcomes [PDF]

open access: bronze, 2000
OBJECTIVESWe compared in-hospital and one-year clinical outcomes in patients undergoing debulking followed by stent implantation versus stenting alone for saphenous vein graft (SVG) aortoostial lesions.BACKGROUNDStent implantation in SVG aortoostial ...
Javed Ahmed   +10 more
openalex   +2 more sources

Quality of life in patients with advanced ovarian cancer after primary debulking surgery versus neoadjuvant chemotherapy: Results from the randomised SCORPION trial (NCT01461850)

open access: yesBJOG: an International Journal of Obstetrics and Gynaecology, 2023
To investigate the effect of treatment with neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS), versus primary debulking surgery (PDS), on quality of life (QoL) in patients with advanced epithelial ovarian cancer (EOC).
C. Marchetti   +9 more
semanticscholar   +1 more source

Predictors of residual disease after debulking surgery in advanced stage ovarian cancer

open access: yesFrontiers in Oncology, 2023
ObjectiveOptimal debulking with no macroscopic residual disease strongly predicts ovarian cancer survival. The ability to predict likelihood of optimal debulking, which may be partially dependent on tumor biology, could inform clinical decision-making ...
Farnoosh Abbas-Aghababazadeh   +11 more
doaj   +1 more source

A case of percutaneous tricuspid valve infective endocarditis vegetation debulking using the AngioJet rheolytic catheter system—A novel therapeutic use

open access: yesClinical Case Reports, 2021
In patients with fulminant tricuspid valve infective endocarditis precluded from cardiothoracic intervention based on comorbidities or clinical status, percutaneous vegetation debulking utilizing the AngioJet rheolytic catheter system appears a viable ...
Liam Marsden Back   +3 more
doaj   +1 more source

Will it Crease or Cease? A study of Debulking of Air Pockets in Automated Prepreg Composite Layup [PDF]

open access: yesComposites Part A: Applied Science and Manufacturing, Volume 138, November 2020, 106052, 2021
Automatic draping of carbon-fiber prepreg plies for the aerospace industry is a promising technique for lowering the manufacturing costs and to this end, a thorough in-process quality control is crucial. In this paper, out-of-plane defects in the layup are investigated. After draping, air pockets are occasionally encountered.
arxiv   +1 more source

Residual tumor and primary debulking surgery vs interval debulking surgery in stage IV epithelial ovarian cancer

open access: yesActa Obstetricia et Gynecologica Scandinavica, 2022
It is debated whether women with FIGO (International Federation of Gynecology and Obstetrics) Stage IV epithelial ovarian cancer should be offered primary debulking surgery (PDS) or interval debulking surgery (IDS).
S. M. Sørensen   +6 more
semanticscholar   +1 more source

Case Report: Cytoreductive Surgery and HIPEC Associated With Liver Electrochemotherapy in a Cholangiocarcinoma Patient With Peritoneal Carcinomatosis and Liver Metastasis Case Report

open access: yesFrontiers in Surgery, 2021
Introduction: Cholangiocarcinoma (CCA) is the second most common primary tumor of the liver, and the recurrence after hepatic resection (HR), the only curative therapy, is linked with a worse prognosis.
Mauro Stefano   +11 more
doaj   +1 more source

Developing a Novel Image Marker to Predict the Clinical Outcome of Neoadjuvant Chemotherapy (NACT) for Ovarian Cancer Patients [PDF]

open access: yesComputers in Biology and Medicine 172 (2024): 108240, 2023
Objective Neoadjuvant chemotherapy (NACT) is one kind of treatment for advanced stage ovarian cancer patients. However, due to the nature of tumor heterogeneity, the clinical outcomes to NACT vary significantly among different subgroups. Partial responses to NACT may lead to suboptimal debulking surgery, which will result in adverse prognosis.
arxiv   +1 more source

Home - About - Disclaimer - Privacy